Newsletter | October 15, 2026

10.15.26 -- AI, Site Burden, And Vendor Risks Are Testing Trials

WHERE TRIAL TECHNOLOGY ADDS BURDEN AND RISK

Why Duplicate Data Entry Is Burning Out Clinical Trial Sites

Disconnected systems force sites to enter the same data repeatedly. Explore why duplication, not technology itself, is driving site burden.

 

Clinical Tech Vendor Questions That Expose Data Quality Risks

An RF engineer’s perspective informs a practical checklist for evaluating decentralized trial vendors and identifying where data quality can break.

COST, COORDINATION, AND TRIAL DELIVERY UNDER PRESSURE

How PMCF Costs Are Testing Device Viability And AI Value

Explore the pressures PMCF costs place on device budgets, and how AI-assisted review and real-world data could support more efficient EU compliance.

Why Sponsor-Vendor Transparency Breaks Down Before Delivery

Hidden operational uncertainties can trigger defensive pricing and scope disputes. Learn how early transparency supports stronger trial partnerships.

Four Fixes For Imaging Workflow Gaps In Clinical Trials

Explore how protocol compliance, automated tracking, and better collaboration can help teams prevent imaging data gaps and keep trial workflows on track.

How To Reduce Supply Risk In Cell And Gene Therapy Trials

Learn how visibility, workflow control, and coordination help teams manage supply risk and protect patient-specific treatments in cell and gene therapy trials.

RESOURCES FOR DATA CAPTURE, PAYMENTS, AND EVIDENCE

Central eSource For Clinical Trial Data Capture: CRIO

Patient Payments Technology: Clinical Trial FAQs Answered

Real-World Data And Evidence: Resources For Trial Teams